Cell transformation by the E7 oncoprotein of human papillomavirus type 16: interactions with nuclear and cytoplasmic target proteins - PubMed (original) (raw)

Review

Cell transformation by the E7 oncoprotein of human papillomavirus type 16: interactions with nuclear and cytoplasmic target proteins

W Zwerschke et al. Adv Cancer Res. 2000.

Abstract

The E7 oncoprotein of human papillomavirus type 16 (HPV-16) has long been known as a potent immortalizing and transforming agent. However, the molecular mechanisms underlying cell transformation and immortalization by E7 remain largely unknown. It is believed that E7 exerts its oncogenic function at least in part by modulating cellular growth regulatory pathways. Increasing experimental evidence suggests that cell transformation by E7 is mediated by the physical association of E7 with cellular regulatory proteins, whose functions are specifically altered by E7, as exemplified by the well-known interaction of E7 with the retinoblastoma protein. In this review, we summarize the available data on the interaction of E7 with cellular regulatory factors and functional consequences of these interactions. We will focus the review on a set of recently identified new target proteins for the E7 oncoprotein, which sheds new light on E7 functions required for cell transformation and immortalization. Similar to the case of the E6 protein of HPV-16, whose interaction with p53 was long considered its major activity, it now appears that the interaction of E7 with the retinoblastoma protein represents just one of many distinct interactions that are relevant for cell transformation.

PubMed Disclaimer

Cited by

Multiple interference of the human papillomavirus-16 E7 oncoprotein with the functional role of the metastasis suppressor Nm23-H1 protein.
Mileo AM, Piombino E, Severino A, Tritarelli A, Paggi MG, Lombardi D. Mileo AM, et al. J Bioenerg Biomembr. 2006 Aug;38(3-4):215-25. doi: 10.1007/s10863-006-9037-y. J Bioenerg Biomembr. 2006. PMID: 17103045
Epithelial progenitor cell lines as models of normal breast morphogenesis and neoplasia.
Petersen OW, Gudjonsson T, Villadsen R, Bissell MJ, Rønnov-Jessen L. Petersen OW, et al. Cell Prolif. 2003 Oct;36 Suppl 1(Suppl 1):33-44. doi: 10.1046/j.1365-2184.36.s.1.4.x. Cell Prolif. 2003. PMID: 14521514 Free PMC article. Review.
Subcellular localization of the human papillomavirus 16 E7 oncoprotein in CaSki cells and its detection in cervical adenocarcinoma and adenocarcinoma in situ.
Dreier K, Scheiden R, Lener B, Ehehalt D, Pircher H, Müller-Holzner E, Rostek U, Kaiser A, Fiedler M, Ressler S, Lechner S, Widschwendter A, Even J, Capesius C, Jansen-Dürr P, Zwerschke W. Dreier K, et al. Virology. 2011 Jan 5;409(1):54-68. doi: 10.1016/j.virol.2010.09.024. Epub 2010 Oct 23. Virology. 2011. PMID: 20970819 Free PMC article.
Maintenance of cell type diversification in the human breast.
Fridriksdottir AJ, Villadsen R, Gudjonsson T, Petersen OW. Fridriksdottir AJ, et al. J Mammary Gland Biol Neoplasia. 2005 Jan;10(1):61-74. doi: 10.1007/s10911-005-2541-6. J Mammary Gland Biol Neoplasia. 2005. PMID: 15886887 Review.
Induction of tetrasomy by human papillomavirus type 16 E7 protein is independent of pRb binding and disruption of differentiation.
Southern SA, Lewis MH, Herrington CS. Southern SA, et al. Br J Cancer. 2004 May 17;90(10):1949-54. doi: 10.1038/sj.bjc.6601827. Br J Cancer. 2004. PMID: 15138476 Free PMC article.

Cell transformation by the E7 oncoprotein of human papillomavirus type 16: interactions with nuclear and cytoplasmic target proteins - PubMed (original) (raw)